Impact of co-payment level increase of antidiabetic medications on glycaemic control: an interrupted time-series study among Finnish patients with type 2 diabetes

BACKGROUND: A new special reimbursement scheme (SRS) for non-insulin medications used for treatment of hyperglycaemia in type 2 diabetes (T2D) was implemented in Finland on January 1, 2017. The new SRS affected all community-dwelling Finnish T2D patients as all community-dwelling residents are eligi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lavikainen, Piia, Aarnio, Emma, Jalkanen, Kari, Tirkkonen, Hilkka, Rautiainen, Päivi, Laatikainen, Tiina, Martikainen, Janne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694920/
https://www.ncbi.nlm.nih.gov/pubmed/33246453
http://dx.doi.org/10.1186/s12913-020-05952-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694920/
https://www.ncbi.nlm.nih.gov/pubmed/33246453
http://dx.doi.org/10.1186/s12913-020-05952-6

Ejemplares similares